Kathleen S. Ensbey - Concepedia

Author

Kathleen S. Ensbey

QIMR Berghofer Medical Research Institute

Also Known As

Ensbey, Kathleen S., K S Ensbey, K. Ensbey, K. S. Ensbey, Kathleen Ensbey, Kathleen S Ensbey, Kathleen S. Ensbey, Kathleen S. Ensbey

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

QIMR Berghofer Medical Research Institute The University of Queensland Fred Hutch Cancer Center Royal Brisbane and Women's Hospital University of Washington Medical Center

About

Kathleen S. Ensbey is an author at QIMR Berghofer Medical Research Institute specializing in medicine, cell biology, and glioma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	492
2	Health Sciences	2	2	55
3	Social Sciences	2	2	27
4	Allergy	1	1	35
5	Biomedical Engineering	1	1	66

Kathleen S. Ensbey

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
EphA3 Maintains Tumorigenicity and Is a Therapeutic Target in Glioblastoma Multiforme Bryan W. Day, Brett W. Stringer, Fares Al‐Ejeh, Cancer Cell Neuro-oncologyGliomaGlioblastoma MultiformeEpha3 Maintains TumorigenicityMedicine	2013	214
A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma Brett W. Stringer, Bryan W. Day, Rochelle C. J. D’Souza, Scientific Reports	2019	210
A Role for Homologous Recombination and Abnormal Cell-Cycle Progression in Radioresistance of Glioma-Initiating Cells Yi Chieh Lim, Tara L. Roberts, Bryan W. Day, Molecular Cancer Therapeutics	2012	91
Increased sensitivity to ionizing radiation by targeting the homologous recombination pathway in glioma initiating cells Yi Chieh Lim, Tara L. Roberts, Bryan W. Day, Molecular Oncology	2014	69
Glioma Surgical Aspirate: A Viable Source of Tumor Tissue for Experimental Research Bryan W. Day, Brett W. Stringer, John Wilson, Cancers Surgical OncologyTumor InnervationOncologic ImagingCell CultureViable Source	2013	66
Cyclin-dependent kinase 7 is a therapeutic target in high-grade glioma Sameer A. Greenall, Yi Chieh Lim, Camilla B. Mitchell, Oncogenesis	2017	64
Endothelial, pericyte and tumor cell expression in glioblastoma identifies fibroblast activation protein (FAP) as an excellent target for immunotherapy Lisa M. Ebert, Wenbo Yu, Tessa Gargett, Clinical & Translational Immunology	2020	63
Nuclear factor one B (<i>NFIB</i>) encodes a subtype-specific tumour suppressor in glioblastoma Brett W. Stringer, Jens Bunt, Bryan W. Day, Oncotarget	2016	45
IL-6 dysregulation originates in dendritic cells and mediates graft-versus-host disease via classical signaling A Wilkinson, Karshing Chang, Rachel D. Kuns, Blood	2019	44
ELK4 neutralization sensitizes glioblastoma to apoptosis through downregulation of the anti-apoptotic protein Mcl-1 Bryan W. Day, Brett W. Stringer, Mark Spanevello, Neuro-Oncology	2011	42

Page 1